Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Angewandte Chemie (International Ed. in English)|June 7, 2023
Preparative Scale Applications of C-H Activation in Medicinal ChemistryRita de Jesus, Kerstin Hiesinger, Manuel van GemmerenJournal of Medicinal Chemistry|December 31, 2020
Spirocyclic Scaffolds in Medicinal ChemistryKerstin Hiesinger, Dmitry Dar'in, Ewgenij Proschak, et al.ACS Medicinal Chemistry Letters|June 20, 2020
Computer-Aided Fragment Growing Strategies to Design Dual Inhibitors of Soluble Epoxide Hydrolase and LTA4 HydrolaseLena Hefke, Kerstin Hiesinger, W Felix Zhu, et al.Prostaglandins & Other Lipid Mediators|December 30, 2018
Development of multitarget agents possessing soluble epoxide hydrolase inhibitory activityKerstin Hiesinger, Karen M Wagner, Bruce D Hammock, et al.Chemical Communications (Cambridge, England)|October 21, 2025
Click chemistry enables rapid development of potent sEH PROTACs using a direct-to-biology approachJulia Schönfeld, Nick Liebisch, Steffen Brunst, et al.Bioorganic & Medicinal Chemistry|October 13, 2016
Pyrazolo[1,5a]pyrimidines as a new class of FUSE binding protein 1 (FUBP1) inhibitorsStefanie Hauck, Kerstin Hiesinger, Sabrina Khageh Hosseini, et al.Chemmedchem|December 7, 2020
Systematic Assessment of Fragment Identification for Multitarget Drug DesignSteffen Brunst, Jan S Kramer, Whitney Kilu, et al.ACS Medicinal Chemistry Letters|March 19, 2020
Design of Dual Inhibitors of Soluble Epoxide Hydrolase and LTA4 HydrolaseKerstin Hiesinger, Annika Schott, Jan S Kramer, et al.The Journal of Organic Chemistry|October 22, 2024
Oxadiazolone-Based Aromatic Annulations: A Nitrenoid Precursor for Tricyclic AminoheterocyclesW Felix Zhu, Hanna M Franz, Andreas Krämer, et al.ACS Medicinal Chemistry Letters|July 21, 2022
Designing a Small Fluorescent Inhibitor to Investigate Soluble Epoxide Hydrolase Engagement in Living CellsSteffen Brunst, Julia Schönfeld, Peter Breunig, et al.Pageof 2